Body Vision Medical, a Ramat Ha Sharon, Israel-based medical device company, raised $8.5m in funding.
The financing round was led by Mr. Zohar Gilon, the Chairman of the Board.
The company intends to use the proceeds to accelerate the commercialization efforts of its FDA approved LungVision™ system in the U.S. and to extend its product line.
Founded in 2014 by Dorian Averbuch, CEO, Body Vision Medical is a software and medical device company specializing in augmented real-time fusion imaging, artificial intelligence and intra-body navigation.
The LungVision™ system, together with a delivery device, enables the physician to plan the procedure, navigate to challenging locations and localize the lesion during biopsy. This complete solution will facilitate early stage diagnosis of lung cancer and minimally invasive transcatheter therapeutics.